Molecular Testing in HNSCC | OncLive
Molecular Testing in HNSCC | OncLive
Jul 19, 2021
onclive.com
Dr Mattes on the Mechanism of Action of Ipatasertib in HNSCC | OncLive
1:38
Dr Mattes on the Mechanism of Action of Ipatasertib in HNSCC | O…
4 weeks ago
onclive.com
Dr Sher on the Efficacy and Safety of Daily Adaptive Radiotherapy in HNSCC | OncLive
Dr Sher on the Efficacy and Safety of Daily Adaptive Radiotherapy in …
Oct 12, 2023
onclive.com
Important updates on locally advanced head and neck squamous cell carcinoma (LA-HNSCC) were presented this year at the #ESMO20 Virtual Congress. In this video, Jean Bourhis reports on key results from the GORTEC 2015-01 “PembroRad” trial testing pembrolizumab vs cetuximab, concomitant with radiotherapy in LA-HNSCC. For more ESMO videos ▶️ http://ow.ly/BeEW50CPkTi #oncology #educationforLIFE | ESMO - European Society for Medical Oncology
3:11
Important updates on locally advanced head and neck squamo…
2K viewsDec 27, 2020
FacebookESMO - European Society for Medical Oncology
Historic Perspective on Systemic Therapy for Advanced HNSCC | OncLive
Historic Perspective on Systemic Therapy for Advanced HNSCC | O…
Dec 22, 2016
onclive.com
Nivolumab demonstrated superior efficacy in LA-HNSCC, abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and lazertinib showed OS improvement in NSCLC, and sunvozertinib has been granted priority review status for NSCLC. READ MORE: https://hubs.li/Q0338gq80 | Targeted Oncology
1:35
Nivolumab demonstrated superior efficacy in LA-HNSCC, abenaciani…
73 viewsJan 20, 2025
FacebookTargeted Oncology
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizumab in HPV16 HNSCC | OncLive
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizu…
Oct 14, 2024
onclive.com
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
10 months ago
oncologytube.com
Genetic Landscape of HNSCC
Aug 10, 2017
onclive.com
8:21
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) T…
Jun 16, 2024
onclive.com
Dr Mehra on the Use of Amivantamab Plus Pembrolizuma…
2 weeks ago
onclive.com
UbiVac Announces Preliminary Immunological Data from 1st-In-H…
Apr 8, 2022
einnews.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
8 months ago
onclive.com
Dr. Bourhis on the OS Benefit of Xevinapant Plus Chemoradiothera…
Oct 28, 2022
onclive.com
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizum…
Jul 15, 2024
onclive.com
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
Dr Siu on the Rationale for Combining Petosemtamab With P…
Oct 4, 2024
onclive.com
Dr Uppaluri on the Implications of the FDA Approval of Perioperativ…
8 months ago
onclive.com
Pembrolizumab/carboplatin/paclit…
501 viewsSep 14, 2022
ecancer.org
33:50
Immunotherapy for recurrent or metastatic HNSCC: What are the p…
824 viewsJan 31, 2022
YouTubeTouch Medical Media
30:54
Staying ahead of the curve in HNSCC care: Refining the role of i…
32 views4 months ago
YouTubeTouch Medical Media
0:49
Ficerafusp alfa: a potential treatment for HNSCC and other E…
11 months ago
linkedin.com
59:45
Mount Sinai Dept. of Otolaryngology Modeling Dormancy and Metastasi…
375 viewsDec 28, 2016
YouTubeMount Sinai Health System
8:19
Cetuximab use for HNSCC
1.2K viewsMay 25, 2016
YouTubeOncLive
11:57
Immunotherapy in HNSCC
2.2K viewsJun 20, 2016
YouTubeOncLive
5:14
Immunotherapy for Recurrent HNSCC
321 viewsFeb 20, 2017
YouTubeOncLive
1:03
Dr Sun on Tisotumab Vedotin in Recurrent or Metastatic HNSCC
145 viewsJun 26, 2024
YouTubeOncLive
4:39:32
Clinical Trial Endpoint for Locally Advanced Head and Neck Squamo…
2.7K viewsNov 9, 2021
YouTubeU.S. Food and Drug Administration
3:37
基于配体受体组的HNSCC分子分型与预后关联
6 views11 months ago
bilibili影像组学科研学习
Therapy Testing in a Spheroid-based 3D Cell Culture Model for H…
Oct 29, 2024
nih.gov
See more videos
Static thumbnail place holder